What Treatment for Patients With Phlebitis or Pulmonary Embolism ?

• Conditions: Venous Thrombosis or Pulmonary Embolism
• Interventions: Other: anticoagulation choice

• Registration Number: NCT03889457
• Lead Sponsor: Rennes University Hospital

Brief Summary

The objective of the "anticoagchoice" study is to analyze the preferences of people suffering from phlebitis, in terms of anticoagulant, to improve adherence to these treatments, to adapt the medical prescriptions.

Detailed Description

Venous thromboembolism (VTE) is the third leading cause of cardiovascular death, with an increase in annual incidence with age. With the advent of direct oral anticoagulants, the management of deep vein thrombosis and pulmonary embolism has evolved in recent years and these treatments are widely prescribed. There are studies comparing the different anticoagulant treatments used in venous thrombosis, which show no inferiority of treatment (injectable or oral) compared to others. Drug delivery modalities have been shown to affect adherence, and thus treatment efficacy. It seems fundamental to focus on patients' drug preferences in VTE to ensure the best possible compliance. These preferences seem to depend on the personal history of each patient. In addition, no studies have been conducted on patient preferences for anticoagulant therapy for VTE: this is the goal of the "anticoagchoice" study.

Study Timeline

• Status Verified: 2019-02
• Study Start: 2019-02-12
• Study First Submitted: 2019-03-15
• Study First Submitted QC: 2019-03-21
• Last Update Submitted: 2019-03-21
• Study First Posted: 2019-03-26
• Last Update Posted: 2019-03-26
• Primary Completion: 2021-02-12
• Study Completion: 2021-02-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

• Patients with deep vein thrombosis, superficial vein thrombosis, muscle vein thrombosis or pulmonary embolism, over 18 years of age.

No Exclusion Criteria

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Patients with venous thromboembolic disease	anticoagulation choice	Patients with deep vein thrombosis, superficial or muscular vein thrombosis, pulmonary embolism, over 18 years of age.

Primary Outcome Measures

Name	Time	Method
The primary objective of this study is to analyze patient treatment preferences in venous thromboembolic disease.	the time required for a consultation: 30 minutes	The primary outcome: To compare the proportion of patients choosing oral anticoagulation vs patients choosing injectable route.

Secondary Outcome Measures

Name	Time	Method
compare patients choosing oral anticoagulation vs patients choosing an injectable route	the time required for a consultation: 30 minutes	Identify factors influencing these choices, depending on the characteristics of the patient (history, age, gender, social environment, personal experience).

Trial Locations

Locations (1)

Rennes University Hospital; 🇫🇷 Rennes, France